Morgan Stanley’s Alpha Tau Medical DRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding DRTS
GIA
BFM
AF
PC
AC
AIM
Morgan Stanley's DRTS Position: Q2 2026 in Review
Morgan Stanley increased its Alpha Tau Medical (DRTS) stake by 73% in Q2 2026, buying an estimated $162K and bringing the position to 42,354 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #5523.
Morgan Stanley first reported a position in DRTS in Q1 2022 and has held it in 18 quarters since. The position peaked at $919K in Q4 2023. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.
- Morgan Stanley held 42,354 shares of Alpha Tau Medical worth $533K as of Q2 2026.
- Morgan Stanley bought 17,883 Alpha Tau Medical shares in Q2 2026, an estimated $162K.
- Alpha Tau Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5523 holding.
- Morgan Stanley first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 18 quarters since.
- Morgan Stanley's Alpha Tau Medical position peaked at $919K in Q4 2023.
- 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.